bpc 157 and parkinson's Multifunctionality Possible Medical Application of the Peptide—Literature and Patent Review bpc-157 parkinson's disease BPC-157 –

US20200102274A1 - Quinoline derived small molecule inhibitors of nicotinamide n-methyltransferase (nnmt) and uses thereof - Google Patents Quinoline derived small molecule inhibitors of nicotinamide n-methyltransferase (nnmt) and uses thereof Download PDF Info Publication number US20200102274A1 US20200102274A1 US16/499,228 US201816499228A US2020102274A1 US 20200102274 A1 US20200102274 A1 US 20200102274A1 US 201816499228 A US201816499228 A US 201816499228A US 2020102274 A1 US2020102274 A1 US 2020102274A1 Authority US United States Prior art keywords nnmt cations amino cation adipocytes Prior art date Legal status (The legal status is an assumption and is not a legal conclusion

5-Amino-1MQ (5-Amino-1-Methylquinolinium) is a small molecule that selectively inhibits nicotinamide N-methyltransferase (NNMT)

Component B: TB-500 (Synthetic Thymosin Beta-4 Fragment) TB-500 is a synthetic version of the naturally occurring protein Thymosin Beta-4 (T4)

When sourcing from Peptide Science , researchers receive a compound engineered for high bioavailability and consistent experimental outcomes